Ozempic's early success in kidney disease trial drags on dialysis stocks - Yahoo Finance


10/11/2023

Ozempic's early success in kidney disease trial drags on dialysis stocks  Yahoo FinanceNovo Nordisk stops Ozempic kidney trial after early signs of success  ReutersDialysis-company stocks slide after Ozempic trial's success in treating kidney disease  MarketWatchDialysis Providers Are the Top Decliners in the S&P 500 Wednesday  Barron'sPharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit  STATView Full Coverage on Google News...

Original

Tags: california | coverage | disease | early | finance | full | google | news | ozempic | signs | stocks | success | top | trial | yahoo



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top